Rob
TS Team
- Favourite Ride
- Steel Vengeance
The updated BBC report now confirms that as well as the Novavax vaccine being 89.3% efficient in the UK trial, indicating good protection against the variant first found in Kent, it was 60% efficient in the South Africa trial where the variant of concern is widely circulating.
So that indicates a roughly 30% reduction in protection against the SA variant, which isn't too bad at all. And the fact it works in 60% of cases suggests that even if it does not prevent infection in the other 40% it would hopefully reduce severity.
So that indicates a roughly 30% reduction in protection against the SA variant, which isn't too bad at all. And the fact it works in 60% of cases suggests that even if it does not prevent infection in the other 40% it would hopefully reduce severity.